Dermapharm Holding SE
DMPHF
$38.50
-$2.12-5.23%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.67% | 2.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.67% | 1.93% | |||
| Cost of Revenue | -7.12% | -12.52% | |||
| Gross Profit | -0.30% | 11.75% | |||
| SG&A Expenses | 7.92% | -5.82% | |||
| Depreciation & Amortization | 9.84% | 10.62% | |||
| Other Operating Expenses | 7.72% | 1,243.52% | |||
| Total Operating Expenses | 1.67% | 12.42% | |||
| Operating Income | -22.63% | -28.68% | |||
| Income Before Tax | -29.37% | 41.91% | |||
| Income Tax Expenses | -23.83% | 4.88% | |||
| Earnings from Continuing Operations | -32.13% | 72.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -98.95% | -85.92% | |||
| Net Income | -32.54% | 60.81% | |||
| EBIT | -22.63% | -28.68% | |||
| EBITDA | -14.32% | -11.04% | |||
| EPS Basic | -32.17% | 60.00% | |||
| Normalized Basic EPS | -29.44% | 10.38% | |||
| EPS Diluted | -32.17% | 60.00% | |||
| Normalized Diluted EPS | -29.44% | 10.38% | |||
| Average Basic Shares Outstanding | -0.57% | 0.51% | |||
| Average Diluted Shares Outstanding | -0.57% | 0.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||